Use of selected honey
The potency of honey's antibacterial activity can vary up to a hundred-fold. 2 Honey's antibacterial activity is partly due to the high osmolarity created by its sugar content, although this reduces as it is diluted by exudate. Honey with no antibacterial activity beyond its osmolarity ceases to be effective against Staphylococcus aureus when diluted with three or four times its volume of exudate. 3 However, honey produced specifi cally for wound care can still be inhibitory if diluted to 45-60 times its volume.
Honey's antimicrobial activity is also due to: • Hydrogen peroxide, which is formed in a 'slowrelease' manner by the glucose oxidase added by bees during its production • Phytochemicals from the nectar of particular plant species.
Both activities can vary from sample to sample. In manuka honey (Leptospermum scoparium manuka honey (Leptospermum scoparium manuka honey ( ) and honey from some other Leptospermum species the phytochemical activity can be high, with a broad spectrum of antimicrobial activity. (This activity, the Unique Manuka Factor, is rated as the UMF number on honeys on sale.)
Honey with a median level of hydrogen-peroxide activity and manuka honey with a median level of phytochemical activity are equally as potent as antibacterial agents in vitro, 4 although manuka honey is about twice as effective against enterococci. 5 In wound care the catalase in serum and tissues decomposes to some extent the hydrogen peroxide produced by many honeys, whereas the phytochemical component of Leptospermum honey maintains its activity. Also, the glucose oxidase which produces the hydrogen peroxide in honey only becomes active when honey is diluted, and its acidity is neutralised by exudate. In contrast, the phytochemical factor in Leptospermum honey is active in full-strength honey, giving a more potent antibacterial action that diffuses into the depth of infected tissues, making it the honey chosen for sale for wound care.
Dressing protocols
The progressive dilution of honey by exudate, together with the absorption of its components into the blood stream, means its osmotic and antiseptic effects last for only two to three days. 6 Other practical issues that need to be considered when using honey as a wound dressing are described below.
The osmotic effect
Honey creates a moist environment by drawing exudate to the wound surface, creating a non-adherent interface between the dressing and wound bed. Lawrence 6 suggested that penetrative osmosis may damage wound tissue, but this does not happen as the underlying circulation provides a fl ow of replacement fl uid. 7 However, osmotic withdrawal of fl uid does prevent maceration of periwound skin.
Dealing with exudate
Wound exudate can dilute a honey's antibacterial activity, or wash it away, so honey is best soaked into a dressing and covered with a secondary dressing, rather than applied directly to the wound.
Due to its anti-infl ammatory action, placing suffi cient honey on the wound will decrease the level of exudate.
8 Until this decrease occurs, frequent dressing changes may be needed on exuding wounds if the honey is being washed away. A new dressing, 9 comprising honey gelled with sodium alginate, forms a rubbery sheet similar to a hydrocolloid. This swells into a softer gel as it readily absorbs exudate, keeping honey in contact with the wound bed while preventing the lateral spread of exudate. A honey hydrogel product (L-Mesitran Hydro, Triticum) can 
Results observed in clinical practice
In our clinical experience a variety of chronic, acute, infected or heavily colonised wounds that did not respond to 'normal management' have been treated with honey. Successful healing was achieved in all patients except those with arterial insuffi ciency. However, the latter wounds remained free from infection and did not deteriorate further. Varicose ulcers usually healed within three months, including cases where compression could not be used. No patients required systemic antiobiotics. As a result, community nurses in our region use honey as the standard treatment for leg ulcers infected or heavily colonised with Pseudomonas.
The most notable results have concerned honey's rapid (within 24 hours) cleansing and deodorising action, particularly on fungating (malignant) wounds. Honey also reduces infl ammation and exudate levels, and may suppress the growth of tumour cells, as observed in experimental animals.
10,11
The following randomised controlled trials of honey have demonstrated successful outcomes, when compared with other dressing regimens:
• Honey versus povidone-iodine on central vein catheter exit sites of patients on dialysis
12
• Honey versus hydrocolloid on split-thickness skin graft donor sites 13 • Honey versus phenytoin on chronic leg ulcers 14 • Honey versus povidone-iodine with 70% ethanol washes on severe postoperative wound infections.
15 Table 1 gives examples of case reports where honey proved successful after other treatments failed. Many used honey dressings we developed -Combine (Smith & Nephew) dressing pads impregnated with 25-35g of UMF12 or UMF13 manuka honey.
Honey with unspecifi ed antibacterial activity
The possibility that some honeys may give poor results because they have a low level of antibacterial activity was demonstrated in a prospective randomised controlled trial comparing honey with early tangential excision followed by autologous skin grafting for the treatment of burns. 16 Honey did not provide as good infection control as early tangential excision, although skin grafting was required in only 11 of the group treated with honey (n=25).
However, in other clinical trials, the author achieved good infection control with the same dressing regimen. [17] [18] [19] [20] [21] [22] For example, a prospective randomised controlled trial 17 compared Jambhul (Syzygium cumini) honey with silver sulphadiazine in two groups of 50 patients. (One sixth of the total burn area was full-thickness.) In the honey group the 44 positive swabs recorded at baseline reduced 48 Robson 49 Cooper et al. 30 Dunford et al. 31 Dunford et al. 28 Natarajan et al. 50 Dunford et al. 28 Stewart 32 Richards 33 Alcaraz and Kelly 45 Kingsley 51 Anoukoum et al. 24 Gurdal et al.
25
▲ to four after seven days, compared with 42 positive swabs at baseline and 42 after seven days in the silver-sulphadiazine group. Use of honey was associated with a signifi cantly faster rate of healing. Four of the honey-treated wounds required grafting compared with 11 treated with silver sulphadiazine.
Some cases 15,23-27 in Table 1 also used honey with unspecifi ed antibacterial activity. Good results were reported in most of these, but the three cases (out of a total of 60) in the trial of Mediprof HoneySoft dressing in which there was infection or failure to heal may be a refl ection of the fact that this honey does not have a standardised antibacterial activity.
Pain and honey dressings
There have been few reports of honey causing pain when applied to wounds.
14,23, 28 In one study the patient experienced pain for the fi rst 20-30 minutes. 28 In another case moderate pain occurred for 15-30 minutes. 29 We have observed that pain is experienced only in very infl amed wounds and disappears once the infl ammation has resolved. But there are many reports of honey relieving pain.
13,15,17,30-33
The pain experienced does not seem to be associated with damage to the wound. But there is evidence that honey stimulates nociceptors. 34 Interestingly, patients have reported a 'peppery' sensation when honey is applied to ulcers.
14 It is possible, therefore, that in some patients the nerve endings are sensitised and thus more responsive to the honey's acidity and/or its organic chemicals.
Acceptance by the medical profession
In 2000 an answer to a reader's question in Journal of Wound Care 35 commented that 'honey appears to be becoming popular for the management of infected wounds'. This has become even more the case, refl ecting the search for alternatives to antibiotics and the increasing awareness of honey's effectiveness.
Although systematic reviews have concluded that there is a low level of evidence to support the use of honey on chronic wounds, 36-38 they have not acknowledged that in many published case reports it was only used after standard treatments failed. (Most of the randomised controlled trials of honey have been on acute wounds.)
Following increasing evidence from laboratorybased research of honey's antimicrobial properties and clinical experience of its ability to promote healing, editorial comments in medical journals are changing from being disparaging [39] [40] [41] to accepting. 35, 42, 43 Honeys produced specifi cally for wound care
There are over 500 reports of case studies and clinical trials where honey intended as a food product has been used as a wound dressing, and none have reported any adverse effects. 8 However, clinicians are reluctant to use non-sterile products on open wounds, and it is unlikely the bacterial content of raw honey would meet regulatory requirements for wound-management products. Although raw honey does not contain disease-causing vegetative bacteria (unless recently contaminated), it can contain viable bacterial spores, including Clostridium species. 44 Several commercially available honeys items produced specifi cally for wound care have been approved by the regulatory authorities:
• Australia, Canada and EU member states -a honey ointment (L-Mesitran, Triticum) comprises honey and Medilan, sunfl ower oil, cod liver oil, aloe vera, calendula, vitamins A, C and E and zinc oxide; L-Mesitran Hydro (Triticum), a hydrogel dressing that contains 30% honey and is also available as an island dressing (L-Mesitran Border) or incorporated into an open-weave polyester net (L-Mesitran Net). The Triticum products are made from honey of unspecifi ed origin and antibacterial activity • Australia and all EU member states -Medihoney Antibacterial Wound Gel, Medihoney Antibacterial Honey Barrier (Medihoney, Australia) and (in Australia) Woundcare 18+ (Comvita Medical, New Zealand). These honeys are harvested from Leptospermum species, and their standardised antibacterial activity stems from the unidentifi ed phytochemical antibacterial component derived from Leptospermum. Medihoney is funded for use in hospitals in Queensland and New South Wales, Australia • All EU member states -Activon Tulle (Advancis) a triple layer of low-adherent knitted viscose primary dressing BP Type 1 impregnated with honey, and Algivon dressing (Advancis), a honey-impregnated mechanically bonded calcium alginate (M type) fi bre dressing. Both are made from Leptospermum honey with standardised antibacterial activity. Activon Tulle is available on the Drug Tariff in the UK 
Conclusion
In 1999 an editorial in Advances in Wound Care commented that there is a 'tremendous opportunity to re-examine old treatments and apply them in the current environment'. 47 Honey, the most ancient of wound treatments, is taking its in place in modern wound care. Like modern wound dressings, it is easy to apply, painless and comfortable, harmless to tissues, creates a moist healing environment, is antibacterial and stimulates healing and epithelialisation.
Potency of honeys' antibacterial activity can be variable -use honey with standardised antibacterial activity
Only use products licensed for wound care as they have been fi nely fi ltered and sterilised by gammairradiation to kill spores Ensure suffi cient honey remains in contact with the wound bed by using absorbent dressings impregnated with honey, or honey gel dressings. Fill any cavities with honey
Ensure the dressings cover any areas of infl ammation surrounding the wound. Due to honey's high osmolarity, there is no risk of skin maceration
Change dressings often enough to prevent the exudate washing the honey out of the dressing
